Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Published January 5, 2022 · Recall initiated: December 3, 2021
Summary
FDA records drug Class I recall D-0299-2022, published January 5, 2022 and initiated December 3, 2021. Recalling firm: Gilead Sciences, Inc.; Status: Terminated; Reported quantity: 53,473 vials; Lot: Lots: 2141001-1A, 2141002-1A, Exp. 01/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VEKLURY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VEKLURY
- Manufacturer
- Gilead Sciences, Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lots: 2141001-1A, 2141002-1A, Exp. 01/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVeklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences,October 9, 2024
- FDAKlean Touch Hand Sanitizer (Ethyl Alcohol 70%) Ingredients Ethanol and Methanol, in 55-gallon drums, AromaJanuary 5, 2022
- FDAMidazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave.January 5, 2022
- FDABetamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc.,January 5, 2022
- FDAMorphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141January 5, 2022
- FDALidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only,January 5, 2022
Questions about this recall
Was Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2 recalled?
Yes. FDA published recall D-0299-2022 on January 5, 2022. Reported hazard: Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VEKLURY.